Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
spermatogenic failure 38
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
05/10/2023
Evidence/Notes:

Spermatogenic failure 38 (SPGF38) is one of many types of spermatogenic failure characterized by asthenozoospermia and associated with variants in a single gene. SPGF38 phenotypes include male infertility due to morphologic abnormalities of the flagella (MMAF) such as shortness, irregular shape, coiling of the tail, and reduced sperm count. Structural analysis of affected flagella have revealed absent central pair complexes, loss of the circular formation of the microtubules (9+2 arrangement), and other structural abnormalities (PMID:30686508).

ARMC2 was first reported in relation to autosomal recessive spermatogenic failure 38 in 2019 (Coutton et al., PMID: 30686508). After a thorough literature search, no patients were found to be published in association with PCD, so ARMC2 was only curated in association with SPGF38.

In this curation, 7 variants (1 missense, 3 nonsense, 2 frameshift, 1 splice site) that have been reported in 7 probands in 3 publications (PMIDs: 30686508, 35543806) are included. All reported probands were homozygous, with 3 families reported as consanguineous. There was one missense variant reported (c.2279T>A, p.Ile760Asn). Immunostaining or RNA analysis could not be performed on the patient’s sperm to verify the impact of the missense change due to lack of a biological sample (PMID:30686508). There is also a splice site variant included in this curation, which the authors confirmed to skip exon 8 and result in an early termination codon in exon 9 (18 exons total) at the RNA level (PMID:30686508). The other 5 variants were predicted null variants which formed a stop codon upstream of the last 50 base pairs of the penultimate exon, and are therefore expected to undergo nonsense-mediated decay. The mechanism of pathogenicity appears to be LOF.

This gene-disease relationship is also supported by expression studies, biochemical evidence, functional assays, and animal models (PMIDs: 30686508, 34982025, 23715323). GTEx expression data revealed increased expression in the testis compared to other tissues in unaffected individuals, which is consistent with the SPGF38 phenotype (PMID:23715323). Tagged ARMC2 protein was found to be upregulated in regenerating chlamydomonas flagella compared to fully grown flagella, which supports the biochemical role of ARMC2 in axonemal assembly (PMID: 34982025). Functional alteration of patient sperm cells was observed through the absence of SPAG6, a known marker of the central pair complex. This supports the suspected role of ARMC2 mutations in contributing to the absent central pair complex flagellar phenotype (PMID:30686508). A chlamydomonas model demonstrates flagellar immotiltiy (0% velocity) similar to human patients with SPGF38. Additionally, the armc2/pf27 mutants also had radial spokes limited to the proximal region of the flagella, which is consistent with the structural defects seen in flagellar cross-sections of patients (PMID:34982025). The immotility and mislocalized radial spoke phenotypes seen in the armc2/pf27 null chlamydomonas model were rescued using a wild-type copy of chlamydomonas ARMC2 (PMID:34982025). Finally, a mouse model generated using the CRISPR-Cas9 system recapitulated the male infertility, MMAF (short, coiled, or thick), and reduced sperm count phenotypes seen in SPGF38 patients (PMID:30686508).

In summary, ARMC2 is definitively associated with autosomal recessive spermatogenic failure 38. This has been repeatedly demonstrated in both research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Motile Ciliopathy GCEP on the meeting date 5/10/2023 (SOP Version [9]).

PubMed IDs:
23715323 30686508 34493464 34982025 35543806
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.